These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 33706585)
1. Long non-coding RNA PITPNA-AS1 regulates UNC5B expression in papillary thyroid cancer via sponging miR-129-5p. Mei S; Zong H; Zhou H Int J Biol Markers; 2021 Mar; 36(1):10-19. PubMed ID: 33706585 [TBL] [Abstract][Full Text] [Related]
2. LncRNA TNRC6C-AS1 regulates UNC5B in thyroid cancer to influence cell proliferation, migration, and invasion as a competing endogenous RNA of miR-129-5p. Hou S; Lin Q; Guan F; Lin C J Cell Biochem; 2018 Nov; 119(10):8304-8316. PubMed ID: 29893424 [TBL] [Abstract][Full Text] [Related]
3. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p. Wang D; Zheng Y Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of the long non-coding RNA UNC5B-AS1/miR-4455/RSPO4 axis reduces cervical cancer growth in vitro and in vivo. Fu J; Zhang Y; Wang M; Hu J; Fang Y J Gene Med; 2021 Dec; 23(12):e3382. PubMed ID: 34350661 [TBL] [Abstract][Full Text] [Related]
5. Long Non-Coding RNA Yuan C; Yang L Cancer Manag Res; 2020; 12():12497-12507. PubMed ID: 33312000 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA LIFR-AS1 suppressed the proliferation, angiogenesis, migration and invasion of papillary thyroid cancer cells via the miR-31-5p/SIDT2 axis. Yi D; Zhang D; He J Cell Cycle; 2021 Dec; 20(24):2619-2637. PubMed ID: 34781815 [TBL] [Abstract][Full Text] [Related]
7. LncRNA MCM3AP-AS1 promotes proliferation and invasion through regulating miR-211-5p/SPARC axis in papillary thyroid cancer. Liang M; Jia J; Chen L; Wei B; Guan Q; Ding Z; Yu J; Pang R; He G Endocrine; 2019 Aug; 65(2):318-326. PubMed ID: 31030335 [TBL] [Abstract][Full Text] [Related]
8. CERS6-AS1 Facilitates Oncogenesis and Restrains Ferroptosis in Papillary Thyroid Carcinoma by Serving as a ceRNA through miR-497-5p/LASP1 Axis. Huang T; Guan S; Wang C Ann Clin Lab Sci; 2022 May; 52(3):426-438. PubMed ID: 35777805 [TBL] [Abstract][Full Text] [Related]
9. [Effects of LncRNA UNC5B-AS1 on adhesion, invasion and migration of lung cancer cells and its mechanism]. Tan JJ; Long SZ; Zhang T Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2020 Nov; 36(6):622-627. PubMed ID: 33719270 [No Abstract] [Full Text] [Related]
11. Long noncoding RNAs SET-binding factor 2-antisense RNA1 promotes cell growth through targeting miR-431-5p/CDK14 axis in human papillary thyroid cancer. Wen HL; Xu ZM; Wen D; Lin SY; Liang Y; Xie JP Kaohsiung J Med Sci; 2020 Oct; 36(10):808-816. PubMed ID: 32602632 [TBL] [Abstract][Full Text] [Related]
12. LncRNA CALML3-AS1 suppresses papillary thyroid cancer progression via sponging miR-20a-5p/RBM38 axis. Zhang X; Zhang X; Jia Q; Li H; Ma R; Yang G; Yin F; Jiang N; Yin D BMC Cancer; 2022 Mar; 22(1):344. PubMed ID: 35351042 [TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA PITPNA-AS1 promotes cervical cancer progression through regulating the cell cycle and apoptosis by targeting the miR-876-5p/c-MET axis. Guo Q; Li L; Bo Q; Chen L; Sun L; Shi H Biomed Pharmacother; 2020 Aug; 128():110072. PubMed ID: 32460193 [TBL] [Abstract][Full Text] [Related]
14. MYBL2-induced PITPNA-AS1 upregulates SIK2 to exert oncogenic function in triple-negative breast cancer through miR-520d-5p and DDX54. Liu B; Yao P; Xiao F; Guo J; Wu L; Yang Y J Transl Med; 2021 Aug; 19(1):333. PubMed ID: 34353336 [TBL] [Abstract][Full Text] [Related]
15. NR2F1-AS1 regulated miR-423-5p/SOX12 to promote proliferation and invasion of papillary thyroid carcinoma. Yang C; Liu Z; Chang X; Xu W; Gong J; Chai F; Cui D J Cell Biochem; 2020 Feb; 121(2):2009-2018. PubMed ID: 31692033 [TBL] [Abstract][Full Text] [Related]
16. LncRNA UNC5B-AS1 promotes malignant progression of prostate cancer by competitive binding to caspase-9. Tan SF; Ni JX; Xiong H Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2271-2280. PubMed ID: 32196578 [TBL] [Abstract][Full Text] [Related]
17. LncRNA-HCG18 regulates the viability, apoptosis, migration, invasion and epithelial-mesenchymal transition of papillary thyroid cancer cells via regulating the miR-106a-5p/PPP2R2A axis. Zhu Y; Zhao J; Tan L; Lin S; Long M; Peng X Pathol Res Pract; 2021 May; 221():153395. PubMed ID: 33798913 [TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA ABHD11-AS1 functions as a competing endogenous RNA to regulate papillary thyroid cancer progression by miR-199a-5p/SLC1A5 axis. Zhuang X; Tong H; Ding Y; Wu L; Cai J; Si Y; Zhang H; Shen M Cell Death Dis; 2019 Aug; 10(8):620. PubMed ID: 31409775 [TBL] [Abstract][Full Text] [Related]
19. Silencing UNC5B antisense lncRNA 1 represses growth and metastasis of human Colon cancer cells via raising miR-622. Zhang Y; Li Z; Lan Z Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):60-67. PubMed ID: 31852293 [No Abstract] [Full Text] [Related]
20. Long non-coding RNA nuclear enriched abundant transcript 1 (NEAT1) modulates inhibitor of DNA binding 1 (ID1) to facilitate papillary thyroid carcinoma development by sponging microRNA-524-5p. Liao G; Huang Z; Gan T; Wu C; Wang X; Li D Bioengineered; 2022 May; 13(5):13201-13212. PubMed ID: 35635748 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]